These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 27339552)

  • 1. Function-specific virtual screening for GPCR ligands using a combined scoring method.
    Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
    Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Histamine H
    Frandsen IO; Boesgaard MW; Fidom K; Hauser AS; Isberg V; Bräuner-Osborne H; Wellendorph P; Gloriam DE
    Sci Rep; 2017 Jul; 7(1):4829. PubMed ID: 28684785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.
    de Graaf C; Kooistra AJ; Vischer HF; Katritch V; Kuijer M; Shiroishi M; Iwata S; Shimamura T; Stevens RC; de Esch IJ; Leurs R
    J Med Chem; 2011 Dec; 54(23):8195-206. PubMed ID: 22007643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT(3)A, Histamine H(1), and Histamine H(4) Receptors.
    Schultes S; Kooistra AJ; Vischer HF; Nijmeijer S; Haaksma EE; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1030-44. PubMed ID: 25815783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of receptor-ligand interactions at the human histamine H1 receptor by a combined approach of site-directed mutagenesis and computational techniques - or - how to bind the H1 receptor.
    Jongejan A; Leurs R
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):248-59. PubMed ID: 15952243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.
    Sato M; Hirokawa T
    J Chem Inf Model; 2014 Nov; 54(11):3153-61. PubMed ID: 25350693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.
    de Graaf C; Rognan D
    J Med Chem; 2008 Aug; 51(16):4978-85. PubMed ID: 18680279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-free versus conventional cellular assays: Functional investigations on the human histamine H
    Lieb S; Littmann T; Plank N; Felixberger J; Tanaka M; Schäfer T; Krief S; Elz S; Friedland K; Bernhardt G; Wegener J; Ozawa T; Buschauer A
    Pharmacol Res; 2016 Dec; 114():13-26. PubMed ID: 27751876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
    Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
    Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
    Bosma R; Moritani R; Leurs R; Vischer HF
    Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Docking and Drug Discovery in β-Adrenergic Receptors.
    Vilar S; Sobarzo-Sanchez E; Santana L; Uriarte E
    Curr Med Chem; 2017; 24(39):4340-4359. PubMed ID: 28738772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery.
    Topiol S; Sabio M
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1598-602. PubMed ID: 18243704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors.
    Lakkaraju SK; Yu W; Raman EP; Hershfeld AV; Fang L; Deshpande DA; MacKerell AD
    J Chem Inf Model; 2015 Mar; 55(3):700-8. PubMed ID: 25692383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescoring ligand docking poses.
    Zhong S; Zhang Y; Xiu Z
    Curr Opin Drug Discov Devel; 2010 May; 13(3):326-34. PubMed ID: 20443166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual fragment screening: discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints.
    Sirci F; Istyastono EP; Vischer HF; Kooistra AJ; Nijmeijer S; Kuijer M; Wijtmans M; Mannhold R; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2012 Dec; 52(12):3308-24. PubMed ID: 23140085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.